Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

Fig. 3

A prognostic model based on TRGs for predicting the OS of PDAC patients. a PDAC patients were divided into high- and low-risk groups based on their score calculated by the model via lasso regression. b The survival time and status of PDAC patients varied with increasing risk scores. c Patients with lower lasso risk scores showed prolonged OS. d ROC curve demonstrated a high accuracy of the constructed model (AUC = 0.849).

Back to article page